Fannin Innovation Studio is actively seeking Therapeutics interns and has an Open House coming up on May 26th
Fannin primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators in the Texas Medical Center and on a national stage. Fannin develops and de-risks these technologies via preclinical work and engineering up through early clinical trials. Additionally, Fannin builds the business model and use case, resulting in strategic partnerships or acquisitions.
Our internship program provides hands-on operational experience in early-stage life science development. Fannin offers two tracks in our internship program: Therapeutics and Medical Devices. Our interns work closely with established and potential portfolio companies, experientially learning about biomedical commercialization. Interns might be tasked with assisting with due diligence, working on market analysis, assisting with product development, or researching and understanding key regulatory requirements. All interns work closely with the core Fannin team to ensure a beneficial and useful experience.
We have had many interns and Fellows complete our program, and we look forward to receiving interest from more of your members!
Questions? Contact Serena Miggins or Stephanie Vega
https://fannininnovation.com/careers/
- Business for Good: BioPhy AI Can Predict Life-Saving Medicines – The Philadelphia Citizen
… discoveries. AI for drug research. MIT professor Marvin Minsky, a pioneering theorist in the field of AI, made the following prediction during an … - The Gene Therapy Choice: To Be Cured or to Have Children? – The Medicine Maker
Discovery & Development Drug Discovery Predictive AI in Drug Discovery: Five Steps to Success. 07/10/2024 | Mirit Eldor | 5 min read. Register to … - Deep Learning In Drug Discovery And Diagnostics Market – openPR.com
Press release – Coherent Market Insights – Deep Learning In Drug Discovery And Diagnostics Market Is Booming Worldwide 2024-2031 |Google Inc., … - ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for …
… drug discovery and automation. July 12, 2024 · Vol.50 No.28 · Drugs & Targets · FDA grants Fast Track designation to 225Ac-FL-020 radiopharmaceutical … - DeepDRA: Drug repurposing using multi-omics data integration with autoencoders – PLOS
Using this model, we could assess drug responses and explore drug repurposing, leading to the discovery of novel cancer drugs. Our study …